Self sufficient and adequate facilities for R&D, manufacturing and quality control of native antigens, cell derived antigens and monoclonal & polyclonal antibodies
Research & Development
Adequate & dedicated facility for research & development of native antigens
ISO 13485:2003 and ISO 9001:2008 based Design Control Procedure
Well equipped for purification process development
